Sweden: Vitrolife finds CEO replacement in Bronwyn Brophy

Vitrolife, a Gothenburg-based provider of medical devices and genetic services improving the outcome of fertility treatment, has settled on Bronwyn Brophy as successor to Thomas Axelsson who announced his decision to step down from the CEO position in September 2022. Brophy will join the company on August 1. Brophy, an Irish national, has experience leading…

You must be a HMI Subscriber to view this content.

Subscribe Now »